<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>药融圈 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2021-01-03T11:41:16+08:00</updated>
  <subtitle>药融圈PHARNEX汇聚数万医药大咖，得到数千家医药创业者鼎力支持，开展日常专题讲座。致力于成为“专业、前沿、权威、严谨”的医药行业资讯平台，以及项目、技术、工厂、融资、股权投资等资源整合平台。欢迎您关注药融圈，共同碰撞“药”的火花!</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>人福医药归核化：做细分市场领导者</title>
    <updated>2021-01-02T22:04:54+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-02:/s/w8Pfk25WJx3aPnj6obKlyQ</id>
    <link href="https://mp.weixin.qq.com/s/w8Pfk25WJx3aPnj6obKlyQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>开局就是冲刺！和生命赛跑，争分夺秒做中国人的自主创新药</title>
    <updated>2021-01-02T22:04:54+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-02:/s/ztwQb8s0wLwXKZ80XQ7qww</id>
    <link href="https://mp.weixin.qq.com/s/ztwQb8s0wLwXKZ80XQ7qww" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>信达PD-1喊出！白菜价！</title>
    <updated>2021-01-02T22:04:54+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-02:/s/M7TuzVoO87iL3ddQXLgdIA</id>
    <link href="https://mp.weixin.qq.com/s/M7TuzVoO87iL3ddQXLgdIA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>作业之大，一页放不下！CDE发布假期作业，20余个指导原则！</title>
    <updated>2021-01-02T22:04:54+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-02:/s/v7s1pYs7xwdU44GhYl6Vcg</id>
    <link href="https://mp.weixin.qq.com/s/v7s1pYs7xwdU44GhYl6Vcg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>恒瑞医药4款产品被纳入医保</title>
    <updated>2021-01-02T22:04:54+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-02:/s/fjLCxmmVi8J540Ccj76Xpw</id>
    <link href="https://mp.weixin.qq.com/s/fjLCxmmVi8J540Ccj76Xpw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>PD-1 后来者寒冬已至？</title>
    <updated>2021-01-02T22:04:54+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-02:/s/n5KiN8r1rBAGREDbcsr8FQ</id>
    <link href="https://mp.weixin.qq.com/s/n5KiN8r1rBAGREDbcsr8FQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>抗体药物今年延续强势</title>
    <updated>2021-01-02T22:04:54+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-02:/s/56F5cbTUjr-PT2f8Qe7rsg</id>
    <link href="https://mp.weixin.qq.com/s/56F5cbTUjr-PT2f8Qe7rsg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>制药人的终究目标之一：乙肝（在研新药盘点）</title>
    <updated>2021-01-01T22:15:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-01:/s/lMSiMAev3MQLk6JHbCB5mA</id>
    <link href="https://mp.weixin.qq.com/s/lMSiMAev3MQLk6JHbCB5mA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>NMPA批准和记黄埔1类创新药索凡替尼胶囊！</title>
    <updated>2021-01-01T22:15:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-01:/s/5V8ngBuu9RMOgp0jWjUJIQ</id>
    <link href="https://mp.weixin.qq.com/s/5V8ngBuu9RMOgp0jWjUJIQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>东阳光2.2类新药磷酸奥司他韦缓释片申报临床</title>
    <updated>2021-01-01T22:15:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-01:/s/LM9K81ehSRBJBvqLBYRy7Q</id>
    <link href="https://mp.weixin.qq.com/s/LM9K81ehSRBJBvqLBYRy7Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>众生睿创流感新药ZSP1273 颗粒剂申报临床</title>
    <updated>2021-01-01T22:15:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-01:/s/hWjzPKe9A1ig-2Pm81MaAw</id>
    <link href="https://mp.weixin.qq.com/s/hWjzPKe9A1ig-2Pm81MaAw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>富祥药业与凌凯医药宣布成立合资公司，加强研发布局</title>
    <updated>2021-01-01T22:15:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-01:/s/RuPeQT85pJDJi7guee5gUA</id>
    <link href="https://mp.weixin.qq.com/s/RuPeQT85pJDJi7guee5gUA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>沃森生物子公司二价HPV疫苗收到注册现场核查通知的公告</title>
    <updated>2021-01-01T22:15:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-01:/s/DjEUUw_qU62t5Bz2Iqbevg</id>
    <link href="https://mp.weixin.qq.com/s/DjEUUw_qU62t5Bz2Iqbevg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>逸达生物完成4700万美元融资，加速产品开发</title>
    <updated>2021-01-01T22:15:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-01:/s/PVGkNSX56yg2CX51_acFNw</id>
    <link href="https://mp.weixin.qq.com/s/PVGkNSX56yg2CX51_acFNw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>Belimumab：儿童系统红斑狼疮适应症中国获批；审评报告出炉</title>
    <updated>2020-12-31T17:29:55+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-31:/s/F1XpAIh39Z6gU9c3gb7oog</id>
    <link href="https://mp.weixin.qq.com/s/F1XpAIh39Z6gU9c3gb7oog" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>投入超2400万元，苑东生物「硫酸氢氯吡格雷片」获批上市</title>
    <updated>2020-12-31T17:29:55+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-31:/s/vNToRwBMPUlaoA5vhnxODQ</id>
    <link href="https://mp.weixin.qq.com/s/vNToRwBMPUlaoA5vhnxODQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>Myovant和Pfizer达成42亿美元交易，合作开发relugolix及商业化</title>
    <updated>2020-12-31T17:29:55+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-31:/s/jSD0Kzb4tC65LiNn1hepRQ</id>
    <link href="https://mp.weixin.qq.com/s/jSD0Kzb4tC65LiNn1hepRQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>卫健委：发布「国家短缺药品」清单、「国家临床必需易短缺药品」清单</title>
    <updated>2020-12-31T17:29:55+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-31:/s/iV-i6_9kjGbMiAtTLjmWYg</id>
    <link href="https://mp.weixin.qq.com/s/iV-i6_9kjGbMiAtTLjmWYg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>上海医药：SPH3127获得美国FDA药品II期临床试验资格</title>
    <updated>2020-12-31T17:29:55+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-31:/s/xhDVrlxEh5RYI0syOfYcaA</id>
    <link href="https://mp.weixin.qq.com/s/xhDVrlxEh5RYI0syOfYcaA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2款印度药获批：太阳药业比卡鲁胺、阿乐滨度泮托拉唑钠肠溶片；37品规药品通过一致性评价；NMPA 12月29日批件信息</title>
    <updated>2020-12-31T17:29:55+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-31:/s/nNJW1807ef57ZRfcvhT8TA</id>
    <link href="https://mp.weixin.qq.com/s/nNJW1807ef57ZRfcvhT8TA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>